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Abstract
Genetic variation in SLC12A5 which encodes KCC2, the neuron-
specific cation-chloride cotransporter that is essential for hyper-
polarizing GABAergic signaling and formation of cortical dendritic
spines, has not been reported in human disease. Screening of
SLC12A5 revealed a co-segregating variant (KCC2-R952H) in an
Australian family with febrile seizures. We show that KCC2-R952H
reduces neuronal Cl extrusion and has a compromised ability to
induce dendritic spines in vivo and in vitro. Biochemical analyses
indicate a reduced surface expression of KCC2-R952H which likely
contributes to the functional deficits. Our data suggest that KCC2-
R952H is a bona fide susceptibility variant for febrile seizures.
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Introduction
GABAergic inhibition in the mammalian brain is conveyed by
the conductance increase associated with the opening of GABAA
receptor channels (GABAARs) (shunting inhibition) and by the
postsynaptic hyperpolarization (voltage inhibition) caused by the
conductive Cl influx along its electrochemical gradient, which is
largely maintained by the neuron-specific K-Cl cotransporter,
KCC2 [1]. During mammalian brain development, the functional
expression of KCC2 undergoes a dramatic increase [1–3] that is
critical for the establishment and maintenance of hyperpolarizing
inhibitory postsynaptic potentials [1]. More recently, rodent
KCC2 has (independently of its role as an ion transporter) been
shown to play an important role as a structural protein required
for the morphological and functional maturation of cortical
dendritic spines [4–6]. Thus, mutations in KCC2 can cause
perturbations in the functions of GABAergic and glutamatergic
transmitter systems and contribute to generation of epileptiform
discharges.
Animal models with expression deficits of KCC2 orthologues
have been described. Mutations in the Drosophila melanogaster KCC
gene kazachoc (kcc) confer increased seizure susceptibility [7]. The
mammalian KCC2 gene generates two N-terminal splice isoforms,
KCC2a and KCC2b, but expression of KCC2b only is strongly up-
regulated during development and accounts for most (> 90%) of the
total KCC2 protein in the adult murine cortex [8]. GABAergic
responses remain depolarizing in KCC2b knockout cortical cultures
[9], indicating that this isoform is responsible for the establishment
of hyperpolarizing GABAAR-mediated transmission [1]. Homozy-
gous KCC2b knockout mice exhibit generalized seizures and die
during the second postnatal week, whereas KCC2b heterozygotes,
which express ~50% of the wild-type (WT) mouse KCC2 (mKCC2)
protein level, show increased susceptibility to pentylenetetrazole-
induced seizures [10].
We analyzed the gene coding for human KCC2, SLC12A5, for
mutations in patients with seizure disorders. Here, we report the
functional characterization of a rare SLC12A5 variant. This missense
variant, resulting in an arginine-to-histidine substitution at position
952 in KCC2b (KCC2-R952H), was found in an Australian family
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with early childhood onset of febrile seizures. Our functional and
structural analyses in rodent cortical neurons in vivo and in vitro
indicate that this mutation brings about deficits in both neuronal
Cl extrusion and the formation of dendritic spines. Functional studies
on rare variants are important as they provide insights into gene
malfunctions which are not accessible through genetic analyses
alone [11]. The significant functional deficit shown in this study,
taken together with the co-segregation in the family and the low
genic tolerance of SLC12A5, is consistent with a role for KCC2-
R952H as a susceptibility gene in febrile seizures.
Results
Identification of the human KCC2 variant
We analyzed 378 (266 unrelated) patients with seizure disorders,
including febrile seizures, febrile seizures plus and generalized
epilepsy, and found a total of 11 rare (minor allele frequency [MAF]
of < 1%) variants in SLC12A5. In one family with febrile seizures
(Fig 1A), a missense variant c.2855G>A (NM_020708.4) was identi-
fied in SLC12A5, and it was not present in ethnically matched
controls. The frequency of this variant is low (MAF 0.07%) in
publicly available variant databases (rs142740233 in NIH dbSNP,
Ensembl 1000 genomes and NHLBI Exome Variant Server), consis-
tent with a role in disease susceptibility. The variant exon will be
present in both KCC2b and KCC2a isoforms with an Arg to His
substitution at positions 952 and 975, respectively. This arginine is
highly conserved across mammalian and avian species (Fig 1B and C).
We selected the shorter KCC2b isoform for further study because it
is preferentially expressed in the cortex and hippocampus and has
been implicated in GABAergic signaling [1]. For convenience, we
refer to the KCC2b variant as KCC2-R952H.
KCC2-R952H was found in a family with febrile seizures
(Fig 1A). In one branch, there were four affected subjects (II-2, II-3,
III-1, III-2) with well-characterized and infrequent febrile seizures
(1–3 attacks) occurring between 12 months and 2.5 years of age.
The variant was inherited from a grandfather (I-2) with no knowl-
edge of childhood febrile seizures (FS) and with no living parents to
confirm his seizure status. For similar reasons, the seizure status of
I-3 could not be confirmed. The inherited variant was present in all
three affected family members tested, with one affected individual
(II-3) not available for genotyping. In the second branch, informa-
tion on the precise phenotype was not available and testing was
limited.
Functional analysis of KCC2-R952H
We used surface protein biotinylation and immunoblotting to
compare the total and cell surface expression levels of KCC2-WT
and the mutated KCC2-R952H protein in a mouse neural stem cell
line (Fig 2). While no difference in the total protein expression
level was observed between KCC2-WT and KCC2-R952H
(98.6  0.16% of WT; P = 0.625), the surface expression of
KCC2-R952H was markedly reduced (61  0.16% of WT;
P = 0.004).
In order to investigate the capacity of KCC2-R952H to transport
Cl, we took advantage of the very low endogenous level of
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Figure 1. Segregation, conservation and location of the KCC2-R952H variant.
A Pedigree of the family with the KCC2-R952H variant, showing segregation of the variant with the febrile seizures phenotype.
B Amino acid sequence alignment of KCC2 shows high conservation of R952 among different species.
C Putative membrane topology of KCC2. R952H is located in the distal part of the intracellular C-terminus.
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functional KCC2 expression in rodent cortical pyramidal neurons
during the first postnatal week [2,12,13]. In utero electroporation
(IUE) with rat KCC2 (rKCC2) has been shown to result in a preco-
cious hyperpolarizing shift in the reversal potential of GABAAR-
mediated currents (EGABA) at postnatal day (P) 6 in somatosensory
layer 2/3 cortical pyramidal neurons [12]. We observed a significant
increase in the Cl extrusion capacity, quantified as the bumetanide-
insensitive somatodendritic EGABA gradient (DEGABA) [2,4,13], in P6-7
mouse somatosensory layer 2/3 cortical pyramidal neurons electro-
porated in utero with human KCC2-WT (DEGABA = 5.01 
0.40 mV/50 lm; P < 0.001 vs. non-transfected EGFP-negative
neurons [control] with DEGABA = 2.24  0.31 mV/50 lm) (Fig 3).
As expected, neurons electroporated with a known transport-deficient
N-terminally deleted rat construct (rKCC2-DNTD) [4] displayed a very
low level of Cl extrusion capacity (DEGABA = 2.07  0.38 mV/
50 lm) that was not different from that observed in EGFP-negative
neurons or those transfected with EGFP alone (DEGABA = 2.19 
0.39 mV/50 lm) (Fig 3C), consistent with lack of functional mKCC2
at this age, cf. for example [2]. In neurons transfected with KCC2-
R952H, the mean Cl extrusion capacity (DEGABA = 3.28 
0.33 mV/50 lm) was slightly higher when compared to non-
transfected controls (P = 0.034; KCC2-R952H vs. control), but failed
to reach the level of Cl extrusion capacity generated by KCC2-WT
(P = 0.002; KCC2-R952H vs. KCC2-WT) (Fig 3C). Thus, the R952H
mutation is associated with deficits in maintaining the Cl driving
force required for hyperpolarizing GABAAR-mediated responses.
The C-terminal domain is critical for both the ion-transport
and structural role of KCC2 [4,5,14]. Our previous work showed
that this domain of rKCC2 interacts with the actin cytoskeleton
[4,15] to promote spine formation [4,5]. IUE of full-length rKCC2,
rKCC2-DNTD, or the isolated C-terminal domain of rKCC2, has
been shown to lead to a persistent increase in the density of
functional dendritic spines of layer 2/3 pyramidal neurons in vivo
during the brain growth spurt [5]. We analyzed the spine density
of Lucifer yellow-filled P15 layer 2/3 pyramidal neurons from
rats, electroporated in utero with either KCC2-WT or KCC2-
R952H. In line with our previous data obtained using rKCC2 [5],
confocal analysis of the second-order dendritic shafts of neurons
co-electroporated with KCC2-WT and EGFP revealed substantially
increased spine densities in both apical (1.56  0.07/lm;
P = 0.012) and basal (1.62  0.01/lm; P = 0.007) dendrites, as
compared to apical (1.18  0.08/lm) and basal (1.35  0.06/lm)
dendrites of neighboring EGFP-negative neurons (Fig 4A). Impor-
tantly, no significant effect on either apical (1.29  0.05/lm;
P = 0.126) or basal (1.18  0.07/lm; P = 0.283) spine density
was observed in neurons co-electroporated with KCC2-R952H and
EGFP when compared to apical (1.18  0.08/lm) and basal
(1.14  0.06/lm) dendrites of the surrounding non-transfected
EGFP-negative neurons (Fig 4A).
In order to further study the effects of the R952H mutation on the
maturation and maintenance of dendritic spines, we used cultured
mouse cortical KCC2/ neurons, which lack mature dendritic
spines and instead display elongated filopodia-like dendritic protru-
sions [4]. We found a rescuing effect on spine length of mKCC2/
neurons after transfection with KCC2-WT (2.19  0.19 lm;
P < 0.001), but not with KCC2-R952H (2.83  0.17 lm; P = 0.3),
when compared to EGFP alone (3.12  0.28 lm) (Fig 4B). Thus,
our present in vivo and in vitro data indicate that the R952H muta-
tion compromises the participation of KCC2 in the formation and
maturation of cortical dendritic spines.
Discussion
To date, no loss-of-function mutation of the SLC12A5 gene
encoding for human KCC2 has been described. Here, we provide
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Figure 2. The R952H substitution in KCC2 leads to a reduction in surface expression.
A Western blot analysis of total protein shows comparable expression levels of KCC2-WT and KCC2-R952H, when heterologously expressed in C17.2 cells.
B Quantification of total (n = 5) and cell surface (n = 9) protein expression of KCC2-R952H, normalized to KCC2-WT. Statistical analysis was performed using Wilcoxon
matched pairs test. **P < 0.01. Error bars represent SEM.
C Representative Western blot of biotinylated (s, surface) and non-biotinylated (i, internal) KCC2-WT and KCC2-R952H. Tubulin and transferrin receptor (TfR) served as
loading controls.
Source data are available online for this figure.
ª 2014 The Authors EMBO reports Vol 15 | No 6 | 2014
Martin Puskarjov et al KCC2 variant from febrile seizure patients EMBO reports
725
a detailed functional analysis of a novel KCC2 missense variant
KCC2-R952H, which was identified in an Australian family with
febrile seizures. Using mammalian cortical expression systems,
we demonstrate that the R952H mutation confers a deficit in
neuronal Cl extrusion capacity (Fig 3). In addition, our data in
vivo (based on IUE) and in vitro (based on cultured mKCC2/
cortical neurons) show that the R952H mutation impairs the
contribution of KCC2 to the formation of dendritic spines (Fig 4).
Notably, R952 is located in the intracellular C-terminal domain of
KCC2 (Fig 1C), which is crucial for both the ion-transport [14]
and structural roles of KCC2 [4,5]. Several residues in the
C-terminus of KCC2, including S940 located in close proximity to
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Figure 3. Cl extrusion capacity measurements from in utero electroporated cortical neurons reveal impaired Cl extrusion by KCC2-R952H.
A IUE of EGFP and either KCC2-WT or KCC2-R952H at embryonic day 14.5 targets mouse cortical layer 2/3 pyramidal neurons (analysis at postnatal day (P) 6).
Transfected neurons co-express either of the KCC2 constructs (red) with EGFP, while endogenous mKCC2 levels in non-transfected neurons at this age are low. Scale
bars: 100 lm and 20 lm (insets).
B Whole-cell patch clamp recordings of GABA uncaging-elicited GABAA-mediated currents (IGABA) in transfected cortical layer 2/3 pyramidal neurons with a somatically
imposed Cl load. Sample EGABA recordings and corresponding I-V curves at the soma and dendrite. Horizontal bars in the sample traces indicate the duration of the
uncaging UV-flash.
C Cl extrusion capacity of P6-7 cortical pyramidal neurons expressing EGFP (n = 8), KCC2-WT (n = 15), KCC2-R952H (n = 16) or rKCC2-DNTD (n = 8) was quantified as
the somatodendritic EGABA gradient (DEGABA = EGABA-soma  EGABA-dendrite). EGFP-negative neurons (n = 17) served as controls. Statistical analysis was performed using
one-way ANOVA with Holm–Sidak post hoc test. *P < 0.05; **P < 0.01. Error bars represent SEM.
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R952, are critical for regulation of KCC2 surface expression [16].
The presently observed decrease in the surface expression of
KCC2-R952H in a neuronal stem cell line (Fig 2) is consistent
with both the decrease in Cl extrusion and deficit in spine
formation.
Our functional analysis of this KCC2 variant in pyramidal
neurons of the mammalian cortex, taken together with the co-segre-
gation and genic intolerance analysis discussed below, is strongly
suggestive of a role for KCC2-R952H as a susceptibility variant in
FS, thereby extending the list of other seizure susceptibility genes
including GABRD, CACNA1H, HCN2 and SCN9A [17–19]. Such
susceptibility variants contribute to epilepsy with complex or poly-
genic inheritance [20]. Rare variants of this kind are not readily
amenable to statistical methods of validation such as genetic associ-
ation studies, as their low frequency means that very large cohorts
would be required to achieve statistical significance. Susceptibility
variants are also refractory to linkage analysis approaches, as they
do not segregate in a Mendelian fashion in large families. In this
context, it is important to note that SLC12A5 is among the 4.5%
most intolerant human genes (http://chgv.org/GenicIntolerance/)
with regard to genic variation, and therefore, mutations in SLC12A5
are good candidates to contribute to disease phenotypes. Given the
fact that KCC2 is a neuron-specific molecule, it is worth noting that
low genic tolerance is prominent in relation to neurodevelopmental
disorders [21].
A strong mechanistic link from the above observations on the
defects of KCC2-R925H to the human febrile seizure phenotype is
provided by studies which have shown that genetic deficits in
mKCC2 expression result in increased network excitability [22] and
higher susceptibility to seizures [10,23]. However, it is not known
whether the enhanced seizure susceptibility in the animal models is
attributable to reduced neuronal Cl extrusion and/or to impair-
ments in spine formation. Seizure-triggering mechanisms show a
wide heterogeneity at the cellular and network level [24]. Thus,
a decrease in the efficacy of KCC2-dependent hyperpolarizing
inhibition is expected to promote triggering of seizures (see
Introduction). In addition, dendritic abnormalities including both
increases and decreases in spine number have been observed in
brain tissue from patients with genetic disorders characterized by a
high prevalence of seizures and epilepsy [25,26]. While an increase
in spine number may enhance overall excitability, a decrease may
lead to desynchronization [27] and thereby promote seizures as
discussed elsewhere [24,28].
In summary, our functional analyses of KCC2-R952H provide a
novel molecular basis for enhanced susceptibility to FS.
Materials and Methods
Patient recruitment
Patients were recruited through private practice, epilepsy clinics and
referral to our epilepsy genetics research program and underwent
phenotyping using a validated seizure questionnaire [29]. Medical
records were obtained where available. Control samples were
anonymous Australian blood donors.
Genetic screening
Patients were screened for mutations in the 26 coding exons of
SLC12A5 by single-stranded conformation analysis (SSCA) using the
GelScan 3000 apparatus (Corbett Research). The sequences of primers
used are listed in Supplementary Table S1. Samples showing
bandshifts were Sanger-sequenced using the BigDye terminator
cycle sequencing kit (Applied Biosystems), and sequencing reac-
tions were analyzed using the ABI 3131 Genetic Analyzer (Applied
Biosystems). Family members of patients showing a rare coding
variant were tested for that variant by direct Sanger sequencing.
Controls were screened for exons showing variants by SSCA as
described above.
A B
Figure 4. KCC2-R952H is unable to induce dendritic spines in vivo or rescue mature spine morphology of cortical mKCC2/ neurons.
A In utero electroporation of E17.5 rat embryos with KCC2-WT leads to an increase of both apical (n = 28 neurons) and basal dendrite (n = 40) spine density of cortical
layer 2/3 pyramidal neurons, when compared to non-transfected neighboring neurons (apical, n = 18; basal, n = 22). In contrast, KCC2-R952H is unable to induce
dendritic spines (transfected: apical, n = 37; basal = 46; non-transfected: apical, n = 22; basal, n = 28). Analysis of spine density was performed on P15. Right panel:
representative confocal images of spine densities. Statistical analysis was performed using Student’s paired t-test. *P < 0.05; **P < 0.01.
B Expression of KCC2-R952H is incapable of rescuing normal spine morphology in cultured mKCC2/ cortical neurons. Aberrant spine morphology of mKCC2/
neurons is rescued by expression of KCC2-WT (n = 19 neurons), but not KCC2-R952H (n = 12) or EGFP (n = 12). Right panel: representative confocal images of spine
lengths. Statistical analysis was performed using the Kolmogorov–Smirnov test. ***P < 0.001.
Data information: Scale bars, 5 lm. Error bars represent SEM.
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Experimental animals
Heterozygous KCC2 mice (KCC2+/) [4] were crossed to produce
KCC2/ embryos. ICR mice and Wistar rats were used for IUE.
Experiments using mice were carried out with the approval by the
National Animal Ethics Committee of Finland and the local Animal
Ethics Committee of the University of Helsinki. Experiments using
rats were conducted according to the guidelines of the Swiss Federal
Veterinary Office and approved by the cantonal Animal Welfare
Committee.
DNA constructs
The constructs expressing KCC2-WT, KCC2-R952H and rKCC2-
DNTD were generated by subcloning the respective KCC2 variant
sequences into the pCAG vector [5,30]. rKCC2-DNTD has been
described previously [4,5,15]. The pCAG-EGFP plasmid was co-
expressed to fluorescently label transfected cells [cf. 5].
Transfection, surface biotinylation and immunoblotting of neural
stem cell cultures
The mouse neural stem cell line C17.2 was cultured at 26°C using
standard methods [15]. Cells at ~80% confluency were transfected
with KCC2-WT or KCC2-R952H expression vectors using Turbofect.
Surface biotinylation and immunoblotting of the cells were
performed as described before [13].
IUE in mice and rats
Timed-pregnant rats with embryonic day (E) 17.5 embryos were
used for IUE with the above-mentioned plasmids. Rats were electro-
porated as previously described [5]. For IUE of mice, the following
modifications to the protocol were applied: Timed-pregnant mice
with E14.5 embryos were anesthetized with isoflurane (4.2% induc-
tion, 2.5% during surgery). All embryos were injected with 2 ll
plasmid DNA solution (in 0.9% NaCl, 0.1% Fast Green). The
plasmid encoding EGFP (1 lg/ll) was injected alone or with KCC2
constructs (3 lg/ll) [5]. Electroporation was done with 5-mm-
diameter circular electrodes (Sonidel Limited) with five pulses (45 V,
50 ms duration at 100 ms intervals), delivered with a square-wave
generator (CUY21vivo SC, Sonidel Limited).
Assessment of the efficacy of KCC2-mediated Cl extrusion in
layer 2/3 pyramidal neurons
Acute 400-lm coronal neocortical slices were used as before [5]. To
measure KCC2-mediated Cl extrusion, we used our standard assay
where a somatic Cl load (19 mM) is imposed on the neuron via a
whole-cell patch pipette. The ensuing bumetanide-insensitive
somatodendritic EGABA gradient, DEGABA, determined as the differ-
ence between the EGABA at the soma and at 50 lm away along the
apical dendrite, provides an accurate estimate of the net Cl extru-
sion [13]. Whole-cell patch clamp recordings were performed as
before [13] in an experiment-blind manner from EGFP-positive layer
2/3 pyramidal neurons from slices of P6-7 mice co-electroporated in
utero with plasmids bearing constructs encoding for EGFP and one
of the following: KCC2-WT, KCC2-R952H or rKCC2-DNTD. Some
animals were electroporated with the EGFP plasmid alone. DPNI-
caged GABA (Tocris) was used to elicit GABAAR-mediated currents
[31]. All recordings were performed in the presence of 10 lM
bumetanide (Tocris), 0.5 lM TTX (Abcam), 10 lM CNQX (Abcam)
and 1 lM CGP 55845 (Abcam) in the standard extracellular solution
[13].
Transfection of mouse primary cortical neurons
E16 mKCC2/ embryos were used for primary neuronal culture [4].
Cortices from each embryo were dissected and plated separately.
Neurons were grown on coverslips coated with poly-D-lysine in
Neurobasal medium supplemented with B27 (GIBCO, Life Technolo-
gies). Transfection was performed on DIV8 using Turbofect
(Thermo Scientific) and experiments at DIV13.
Analysis of spine density and length
Spine density analysis of rat somatosensory layer 2/3 pyramidal
neurons filled iontophoretically with Lucifer yellow was done as
described previously [5]. Spine lengths from cultured neurons were
analyzed on acquired stacks of images using NeuronJ software
(http://rsb.info.nih.gov/ij/). Fluorescence images for dendritic
spine length analysis were acquired with a Zeiss LSM 710 confocal
microscope equipped with a 63× oil-immersion objective.
KCC2 staining in slices from in utero electroporated mice
Detection of KCC2 was done on 30 lm coronal cryosections from
fixed brains (P6 mice, fixed with 4% PFA). Blocking and staining
was performed in 3% BSA, 0.2% saponin, 10% goat serum in PBS
mounted with Vectashield hard set mounting medium. The follow-
ing antibodies were used: rabbit anti-KCC2 antibody (1:1,000;
Millipore), chicken anti-GFP (1:1,000; Abcam), donkey anti-rabbit
Cy3-conjugated (1:1,000; Jackson Immuno Research) and donkey
anti-chicken Alexa 488-conjugated (1:1,000; Jackson Immuno
Research).
Supplementary information for this article is available online:
http://embor.embopress.org
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